跳至主要内容
临床试验/NCT05120609
NCT05120609Unknown不适用

A Randomized, Cross-Over, Placebo-Controlled Pilot Study to Evaluate the Self-Management of Gait, Speech and Dexterity in Patients With Parkinson's Disease Using a Novel Digital Therapeutic Approach

Beats Medical2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2021年12月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
40
试验地点
2
主要终点
Change in Gait Velocity (m/s)

研究概览

简要总结

The purpose of this study is to evaluate the impact of a smartphone application that delivers at-home therapy exercises on patients' self-management of gait, speech, and dexterity symptoms.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
30 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female subjects at least 30 years of age or older,
  • History of idiopathic Parkinson's Disease (Hoehn and Yahr stage of II-IV),
  • Normal joint range of motion in both legs,
  • Able to walk independently for 10 feet with or without an assistive device,
  • Parkinson's gait and mild to moderate speech impairment,
  • No history of vestibular disease,
  • No evidence of dementia (MMSE ≥24),
  • Clear benefit from Levodopa,
  • Agrees to Beats Medical Application Privacy Policy and Terms of Use,
  • Access to an iPhone 7 or higher to use the Beats Medical applications.

排除标准

  • Medical condition for which exercise is contraindicated,
  • History or evidence of neurological deficit other than Parkinson's Disease that could interfere, such as previous stroke or muscle disease,
  • History or evidence of orthopaedic or muscular problems,
  • Subject is currently enrolled in a study to evaluate an investigational drug or device,
  • Subject unable or unwilling to provide informed consent,
  • Vulnerable populations as deemed inappropriate for the study by site Principal Investigator,
  • History of falls in the past 6 months,
  • Pregnancy,
  • Current or previous use of the Beats Medical Parkinson's application.

结局指标

主要结局

Change in Gait Velocity (m/s)

时间窗: Baseline, Week 4, Week 8, Week 12

Gait velocity on a 10-Meter Walk Test (10MWT) conducted in-clinic.

次要结局

  • Step Length (m)(Baseline, Week 4, Week 8, Week 12)
  • MDS-UPDRS Total Score for Part II Item 2.1 + Part III Item 3.1(Baseline, Week 4, Week 8, Week 12)
  • Step Frequency (steps/min)(Baseline, Week 4, Week 8, Week 12)
  • MDS-UPDRS Part II Total Score(Baseline, Week 4, Week 8, Week 12)
  • MDS-UPDRS Total Score for Part II Item 2.7 + Part III Item 3.4 + Part III 3.5(Baseline, Week 4, Week 8, Week 12)
  • Daily steps(Week 1,2,3,4,5,6,7,8)

研究者

发起方
Beats Medical
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Pilot Study to Evaluate the Self-Management of Gait,... | 临床试验